This is a report of a patient treated with hemodiafiltration since (b)(6) 2015 due to a glomerulopathy of undetermined origin.The patient has no known allergies.Prior to the treatment start the patient was in a good clinical condition.After 30 min of treatment using the polyflux 170 h dialyzer for the first time, the patient presented with symptoms of sudden dyspnea with chest pain, spasticity at auscultation and facial erythrosis.The treatment was terminated without blood restitution and immediately the patient felt better.Oxygen, atrovent and ventoline was administered to the patient.Performed ecg was reported to be normal.The treatment was not restarted and the patient returned home.No additional information is available.
|